BCMA is down-regulated from the surface of plasma cells by γ secretase-mediated cleavage, resulting in the production of a soluble form BCMA (sBCMA), which causes a decrease in its expression on tumor cells. This evidence concerns the gene TNFRSF17 and neoplasm.